Lenalidomide VISN 22 BPA

Active Awarded Last action

Contract number
36C26226A0006
Awardee
Awarding agency
Task orders
8 $17,472,307 obligated

Award facts

Opportunity
  • 36C26226Q0097 Solicitation number
Combined order value
$17,472,307 Current and potential, with all options
Last date to order 77% complete
IDV ceiling 83% used
$21,167,021.00
Maximum order
$4,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Veterans Integrated Service Network 22 awarded a Blanket Purchase Agreement to Exelan Pharmaceuticals Inc. on January 15, 2026, with a ceiling value of $21.17 million and an ultimate completion date of January 14, 2027, against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for the supply of Lenalidomide in multiple strengths and formulations.

The BPA establishes a single-award framework for Lenalidomide supply to support oncology and hematologic malignancy treatment protocols across the VA healthcare system. Performance occurs at Exelan's facility in Boca Raton, Florida. No set-aside was used; the BPA was awarded on an unrestricted, fully open basis.

As of January 2026, VISN 22 issued nine BPA calls against this vehicle totaling approximately $18.65 million in ceiling values across multiple VA regional medical centers: VA San Diego ($3.25 million), VA Albuquerque ($2.07 million), VA Loma Linda ($2.11 million), VA Long Beach ($1.09 million), VA Tucson ($2.13 million), VA Greater Los Angeles ($3.48 million), VA Phoenix ($2.52 million), VA Prescott ($1.82 million), and one additional call. All calls are firm-fixed-price orders with completion by January 14, 2027, and all performance remains at the Boca Raton facility. Each call reflects pricing modifications to align with current contract terms.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · Lenalidomide VISN 22 BPA pricing update $0
Original award $0

Quick answers

Who was awarded contract 36C26226A0006?

36C26226A0006 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on January 15, 2026.

How much is contract 36C26226A0006 worth?

Orders under 36C26226A0006 have obligated $17,472,307. 36C26226A0006's own ceiling is $21,167,021. A single order can be worth up to $4,000,000.

How many orders have been placed under contract 36C26226A0006?

8 orders have been placed under 36C26226A0006, the latest on January 28, 2026.

Who can order from contract 36C26226A0006?

36C26226A0006 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36C26226A0006 under another contract?

Yes. 36C26226A0006 is a blanket purchase agreement under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26226A0006 competed?

The extent of competition for 36C26226A0006 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV